These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23451245)

  • 21. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
    Lin CC; Lai MS; Shau WY
    Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association between cholecystectomy and risk of colorectal cancer: a meta-analysis of cohort studies.
    Yu L; Liu W; Yan Y; Jiang Y; Gao X; Ruan S
    Int J Colorectal Dis; 2023 Jun; 38(1):179. PubMed ID: 37368048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of aspirin use and the risk for colorectal adenoma.
    Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary intake of n-3 fatty acids and colorectal cancer risk: a meta-analysis of data from 489 000 individuals.
    Shen XJ; Zhou JD; Dong JY; Ding WQ; Wu JC
    Br J Nutr; 2012 Nov; 108(9):1550-6. PubMed ID: 22906228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin and the risk of colorectal cancer in women.
    Giovannucci E; Egan KM; Hunter DJ; Stampfer MJ; Colditz GA; Willett WC; Speizer FE
    N Engl J Med; 1995 Sep; 333(10):609-14. PubMed ID: 7637720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The non-linear threshold association between aspirin use and esophageal adenocarcinoma: results of a dose-response meta-analysis.
    Xiaohua Y; Zhenjiang Y; Weidong L; Pengcheng X; Sidong C
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):278-84. PubMed ID: 24436316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is aspirin use associated with age-related macular degeneration? A meta-analysis.
    Li L; Li W; Chen CZ; Yi ZH; Zhou YY
    J Clin Pharm Ther; 2015 Apr; 40(2):144-54. PubMed ID: 25475899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
    Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH
    J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin chemoprevention in colorectal cancer: network meta-analysis of low, moderate, and high doses.
    Shah D; Di Re A; Toh JWT
    Br J Surg; 2023 Nov; 110(12):1691-1702. PubMed ID: 37499126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
    Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose aspirin use and cancer-specific mortality: a meta-analysis of cohort studies.
    Wang X; Luo Y; Chen T; Zhang K
    J Public Health (Oxf); 2021 Jun; 43(2):308-315. PubMed ID: 31781767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
    Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies.
    Li L; Gan Y; Wu C; Qu X; Sun G; Lu Z
    BMC Cancer; 2015 Oct; 15():733. PubMed ID: 26481317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose aspirin use and cancer characteristics: a population-based cohort study.
    Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
    Br J Cancer; 2013 Oct; 109(7):1921-5. PubMed ID: 23887604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis between dietary carbohydrate intake and colorectal cancer risk: evidence from 17 observational studies.
    Huang J; Pan G; Jiang H; Li W; Dong J; Zhang H; Ji X; Zhu Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28298476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis.
    Jiang HY; Huang TB; Xu L; Yu J; Wu Y; Geng J; Yao XD
    PLoS One; 2015; 10(4):e0122962. PubMed ID: 25849465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Aspirin Reduce the Risk of Endometrial Cancer?: A Systematic Review and Meta-analysis of Observational Studies.
    Zhang D; Bai B; Xi Y; Zhao Y
    Int J Gynecol Cancer; 2016 Jul; 26(6):1111-20. PubMed ID: 27177285
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.